Review article · 2026 · Open access
Obstetric Pharmacomicrobiomics
Clinical Pharmacology & Therapeutics · Published 9 October 2026 · DOI 10.1002/cpt.70520
In brief
“Obstetric Pharmacomicrobiomics” is a 2026 review article by Ahizechukwu Chigoziem Eke, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 1 citations as of 17 November 2026, which puts it in the top 9% of works published in 2026 by citations. It is open access: the full text is free to read at Clinical Pharmacology & Therapeutics.
- Citations
- 1
- Most cited in
- 2026 (1)
- Field-weighted impact
- 0.50
- References
- 43
- Authors
- 1
Abstract
Pregnancy is characterized by physiologic, metabolic, immunologic, and microbial adaptation. Medication use during pregnancy is common. Yet, therapeutic response often remains unpredictable because obstetric pharmacology has historically focused on pharmacokinetic changes while paying little attention to host-microbiome-drug interactions. Pharmacomicrobiomics, the study of bidirectional interactions between the microbiome and therapeutic agents, has emerged as an important frontier in precision medicine. Increasing evidence demonstrates that the maternal microbiome may influence drug bioavailability, metabolism, efficacy, toxicity, immune response, and placental signaling during pregnancy. Conversely, medications used in obstetric practice, including antibiotics, antiretrovirals, metformin, iron supplementation, and proton pump inhibitors, may reshape maternal microbial ecosystems with downstream implications for maternal-fetal health. Pregnancy introduces pharmacomicrobiomic complexity because the maternal gut, vaginal, and oral microbial communities evolve across gestation, while the placenta and fetus are exposed to microbial metabolites and microbe-associated signals without convincing evidence of stable resident microbiomes. Emerging data suggest that microbial composition may influence preterm birth, hypertensive disorders of pregnancy, gestational diabetes mellitus, obesity, fetal growth, immune development, and therapeutic responsiveness. This mini-review examines recent advances in obstetric pharmacomicrobiomics with emphasis on microbial regulation of drug metabolism, pregnancy-associated microbial remodeling, microbiome-mediated therapeutic variability, placental and fetal implications, and future translational applications. We propose that obstetric pharmacology is entering a systems biology era in which the maternal microbiome should be investigated as a potentially important determinant of therapeutic response rather than treated solely as a background physiologic variable. Integrating microbiome science into maternal-fetal therapeutics may ultimately improve individualized treatment strategies, drug development, and precision obstetric pharmacology.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Eke, A. C. (2026). Obstetric Pharmacomicrobiomics. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70520
MLA 9
Eke, Ahizechukwu Chigoziem. “Obstetric Pharmacomicrobiomics.” Clinical Pharmacology & Therapeutics, 2026. https://doi.org/10.1002/cpt.70520.
Chicago
Eke, Ahizechukwu Chigoziem. 2026. “Obstetric Pharmacomicrobiomics.” Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70520.
Harvard
Eke, A. C. (2026) ‘Obstetric Pharmacomicrobiomics’, Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.70520.
IEEE
A. C. Eke, “Obstetric Pharmacomicrobiomics,” Clinical Pharmacology & Therapeutics, 2026, doi: 10.1002/cpt.70520.
BibTeX
@article{eke2026obstetric,
title = {{Obstetric Pharmacomicrobiomics}},
author = {Eke, Ahizechukwu Chigoziem},
journal = {Clinical Pharmacology \& Therapeutics},
year = {2026},
doi = {10.1002/cpt.70520},
url = {https://doi.org/10.1002/cpt.70520}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- maternal microbiome
- drug metabolism
- pregnancy
- gut microbiota
- vaginal microbiota
- oral microbiota
- placenta
- preterm birth
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Eke, A. C. (2026). Obstetric Pharmacomicrobiomics. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70520
How many times has this paper been cited?
1 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.
Who wrote this paper?
Ahizechukwu Chigoziem Eke.
What is the DOI of this paper?
10.1002/cpt.70520, permanently at https://doi.org/10.1002/cpt.70520. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.